BWP
DNA icon

Balboa Wealth Partners’s Ginkgo Bioworks DNA Stock Holding History

Balboa Wealth Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,176
Closed -$85.1K – 295
2023
Q3 		$85.1K Buy
+1,176
New +$94K 0.03% 221

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balboa Wealth Partners's DNA Position: Q4 2023 in Review

Balboa Wealth Partners sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 1,176 shares — an estimated $85.1K sold.

Balboa Wealth Partners first reported a position in DNA in Q3 2023 and held it in 1 quarter. The position peaked at $85.1K in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Balboa Wealth Partners reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Balboa Wealth Partners sold 1,176 Ginkgo Bioworks shares in Q4 2023, an estimated $85.1K.
  • Balboa Wealth Partners first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 1 quarter.
  • Balboa Wealth Partners's Ginkgo Bioworks position peaked at $85.1K in Q3 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Balboa Wealth Partners's 13F filing for Q4 2023, filed 9 Feb 2024.